# US 2025/0205170 A1 · Delmopinol and delmopinol salt containing nanoparticles and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0205170 A1
- Document ID: US20250205170A1
- Status: Published application
- Kind: A1
- Application number: 18/850,002
- Filed: 2023-03-23
- Published: 2025-06-26
- Earliest claimed: 2023-03-23
- Applicants: You First Services, Inc.
- Inventors: Satish SHARMA
- Web page: https://patentgrep.com/patent/US20250205170A1

## CPC

- A61K 9/5153: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 9/5161: {Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin}
- A61K 31/5375: 1,4-Oxazines, e.g. morpholine
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure provides nanoparticles comprising delmopinol and/or the sodium salt of delmopinol. Also provided are methods of using the nanoparticles and methods of making the nanoparticles.

## Claims

### Claim 1

A core-shell nanoparticle comprising a poly(lactic-co-glycolic acid) (PLGA) core and a chitosan shell, wherein the core-shell nanoparticle further comprises delmopinol and/or the sodium salt of delmopinol.

### Claim 2 (depends on 1)

The core-shell nanoparticle according to claim 1, wherein the PLGA is 50:50 lactide:glycolide PLGA with a molecular weight of 30-60 kDa.

### Claim 3 (depends on 1)

The core-shell nanoparticle according to claim 1, wherein the chitosan of the chitosan shell has an average molecular weight of 5 kDa.

### Claim 4 (depends on 1)

The core-shell nanoparticle according to claim 1, wherein the longest linear dimension of the nanoparticle is less than or equal to 200 nm.

### Claim 5 (depends on 1)

The core-shell nanoparticle according to claim 1, further comprising one or more additional cargo.

### Claim 6 (depends on 5)

The core-shell nanoparticle according to claim 5, wherein the one or more additional cargo is one or more antibiotics.

### Claim 7 (depends on 6)

The core-shell nanoparticle according to claim 6, wherein the one or more antibiotics are chosen from penicillins, cephalosporins, tetracyclines, aminoglycosides, macrolides, macrolides, sulfonamides, quinolones, lincosamides, glycopeptides, and combinations thereof.

### Claim 8 (depends on 6)

The core-shell nanoparticle according to claim 6, wherein the one or more antibiotics is chosen from phenoxymethylpenicillin, dicloxacillin, ampicillin, facillin, oxacillin, penicillin V, penicillin G, flucloxacilline, amoxicillin, cefaclor, cefadroxil, cephalexin, cefazolin, cefuroxime, cefixime, cefoxitin, ceftriaxone, tetracycline, doxycycline, minocycline, sarecycline, lymecycline, gentamicin, tobramycin, amikacin, planomycin, streptomycin, neomycin, paromomycin, erythromycin, azithromycin, clarithromycin, clindamycin, fidaxomicin, roxithromycin, trimethoprim, co-trimoxazole, metronidazole, tinidazole, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, moxifloxacin, nitrofurantoin, sulfamethoxazole, sulfasalazine, sulfacetamide, sulfadiazine silver, vancomycin, dalbavancin, oritavancin, telavancin, and combinations thereof.

### Claim 9 (depends on 1)

The core-shell nanoparticle according to claim 1, further comprising a peptide.

### Claim 10 (depends on 9)

The core-shell nanoparticle according to claim 9, wherein the peptide is a targeting peptide.

### Claim 11

A composition comprising a first population of nanoparticles comprising core-shell nanoparticles comprising a poly(lactic-co-glycolic acid) (PLGA) core and a chitosan shell, wherein the core-shell nanoparticle further comprises delmopinol and/or the sodium salt of delmopinol.

### Claim 12 (depends on 11)

The composition according to claim 11, further comprising a second population of nanoparticles comprising core-shell nanoparticles comprising a poly(lactic-co-glycolic acid) (PLGA) core and a chitosan shell, wherein the core-shell nanoparticle further comprises one or more cargo.

### Claim 13 (depends on 11)

The composition according to claim 11, further comprising a third population of nanoparticles core-shell nanoparticles comprising a poly(lactic-co-glycolic acid) (PLGA) core and a chitosan shell, wherein the core-shell nanoparticle further comprises one or more cargo molecules and delmopinol and/or the sodium salt of delmopinol.

### Claim 14 (depends on 12)

The composition according to claim 12, wherein the one or more cargo is one or more antibiotics.

### Claim 15 (depends on 14)

The composition according to claim 14, wherein the one or more antibiotics is chosen from penicillins, cephalosporins, tetracyclines, aminoglycosides, macrolides, macrolides, sulfonamides, quinolones, lincosamides, glycopeptides, and combinations thereof.

### Claim 16 (depends on 14)

The composition according to claim 14, wherein the one or more antibiotics is chosen from phenoxymethylpenicillin, dicloxacillin, ampicillin, facillin, oxacillin, penicillin V, penicillin G, flucloxacilline, amoxicillin, cefaclor, cefadroxil, cephalexin, cefazolin, cefuroxime, cefixime, cefoxitin, ceftriaxone, tetracycline, doxycycline, minocycline, sarecycline, lymecycline, gentamicin, tobramycin, amikacin, planomycin, streptomycin, neomycin, paromomycin, erythromycin, azithromycin, clarithromycin, clindamycin, fidaxomicin, roxithromycin, trimethoprim, co-trimoxazole, metronidazole, tinidazole, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, moxifloxacin, nitrofurantoin, sulfamethoxazole, sulfasalazine, sulfacetamide, sulfadiazine silver, vancomycin, dalbavancin, oritavancin, telavancin, and combinations thereof.

### Claim 17 (depends on 11)

The composition according to claim 11, wherein one or more of the nanoparticles further comprise a peptide.

### Claim 18 (depends on 17)

A composition according to claim 17, wherein the peptide is a targeting peptide.

### Claim 19 (depends on 1, 10)

The container comprising one or more nanoparticles according to claim 1 or claim 10.

### Claim 20 (depends on 1, 11)

An article impregnated with a nanoparticle according to claim 1 or a composition according to claim 11.

### Claim 21 (depends on 20)

The article according to claim 20, wherein the article is a catheter or stent.

### Claim 22 (depends on 20)

The article according to claim 20, wherein the article does not comprise metal.

### Claim 23 (depends on 21)

The article according to claim 21, wherein the article is a catheter and an interior surface and/or exterior surface of the catheter is impregnated with the nanoparticles or the composition.

### Claim 24 (depends on 1, 11)

An article having a surface with a nanoparticle according to claim 1 or a composition according to claim 11 disposed thereon.

### Claim 25 (depends on 24)

The article according to claim 24, wherein the article is a catheter or stent.

### Claim 26 (depends on 24)

The article according to claim 24, wherein the article does not comprise metal.

### Claim 27 (depends on 25)

The article according to claim 25, wherein the article is a catheter and an interior surface and/or exterior surface of the catheter has the nanoparticles or the composition disposed thereon.

### Claim 28

The article according to 24, wherein the nanoparticles or compositions are applied via spray.
